Welcome to NSP

polymer1Nanosoft Biotechnology LLC (Nanosoft Polymers, NSP)  is launched to bridge the gap between polymer and drug delivery by supplying ready-to-use funcitonalized polymer & copolymers. We manufacture and sell a unique collection of functional polymers,  copolymers, and polymer conjugates.  

NSP's phomepage-pic2olymer catalog includes functional PLGA-PEG, PLA-PEG, PCL-PEG, lipid-PEGs, poly(L-lysine)-PEG, poly(L-glutamic acid)-PEG and pegylation reagents that can be used in your research involving drug delivery and surface modification. 

We are committed to exceeding our customers' expectations, whether it is in providing the highest quality and reliable polymer materials, or in our unique services such as consultancy and developing new technologies. 


Our Mission

We are dedicated to building a long-term, trusting relationship with our customers  by offering quality functional polymers and copolymers backed up with exceptional customer service and technical support.

If you have previously worked with functional polymers, give NSP a chance to show you how we can help. If  you are currently looking for functional polymers to design your drug delivery, give us a call and we will help you get started.

High quality

We guarantee the superior quality of our products by providing real analytical data with excellent lot-by-lot reproducibility.

Easy payment

We accept NET 30 days payments, Credit cards, checks, and wire transfers.

Quick delivery

We keep catalog items in stock. Overnight delivery is possible in US. Delivery is quick to other worldwide locations.

Professional support

We provide the highest level of technical support to our customers. Just call us and we will help you!

Great pricing

We provide excellent pricing for our products. Check out our catalog now and compare the prices with our competitors.

Fast turnaround

Our experienced team work together to make sure quick turnaround for your orders.

We commit to

NSP’s Pegylated Lipid contributed to paper in Nano Letters

Go to Volume 19, Issue 2

Ultrathin Tellurium Oxide/Ammonium Tungsten Bronze Nanoribbon for Multimodality Imaging and Second Near-Infrared Region Photothermal Therapy

Developing nanophotothermal agents (PTAs) with satisfied photothermal conversion efficiency (PTCE) in the second NIR window (1000–1350 nm, NIR II) holds great promise for enhanced photothermal therapy effect. Herein, we develop a NIR-II PTA with advanced PTCE, based on a new two-dimensional ultrathin tellurium oxide/ammonium tungsten bronze (TeO2/(NH4)xWO3) nanoribbons (TONW NRs). The doped ammonia ions-mediated-free-electrons injection into the lowest unoccupied molecular orbital band of WO3 combined with the electronic transitions between W6+ ions and the lone pair of electrons in Te atoms achieve excellent NIR absorption of TONW NRs resulting from localized surface plasmon resonance. The polyethylene glycol functionalized TONW NRs (PEG-TONW NRs) exhibit good stability and biocompatibility, displaying a PTCE high to 43.6%, surpassing many previous nano-PTAs active in the NIR II region, leading to remarkable tumor ablation ability both in vitro and in vivo. Meanwhile, advanced X-ray computed tomography (CT) and photoacoustic (PA) imaging capability of PEG-TONW NRs were also realized. Given the admirable photothermal effect in NIR II region, good biocompatibility, and advanced CT/PA imaging diagnosis capability, the novel PEG-TONW NRs is promising in future personalized medicine applications. Nano Lett.2019, 19, 2, 1179-1189.

NSP’s product contributed to Nature Materials

Hyaluronic acid–bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis

While conventional approaches for inflammatory bowel diseases mainly focus on suppressing hyperactive immune responses, it remains unclear how to address disrupted intestinal barriers, dysbiosis of the gut commensal microbiota and dysregulated mucosal immune responses in inflammatory bowel diseases. Moreover, immunosuppressive agents can cause off-target systemic side effects and complications. Recently, a paper published in Nature Biomaterials,  reported the development of hyaluronic acid–bilirubin nanomedicine (HABN) that accumulates in inflamed colonic epithelium and restores the epithelium barriers in a murine model of acute colitis. Surprisingly, HABN also modulates the gut microbiota, increasing the overall richness and diversity and markedly augmenting the abundance of Akkermansia muciniphila and Clostridium XIVα, which are microorganisms with crucial roles in gut homeostasis. Importantly, HABN associated with pro-inflammatory macrophages, regulated innate immune responses and exerted potent therapeutic efficacy against colitis. The work sheds light on the impact of nanotherapeutics on gut homeostasis, microbiome and innate immune responses for the treatment of inflammatory diseases.  Nanosoft Polymers’ Cholesterol-PEG-NH2  was used to conjugate hyaluronic acid for HABN.   2019 Aug 19. doi: 10.1038/s41563-019-0462-9.

NSP’s PEGylated polylysine contributed to paper in Nature Communications

Mammalian cells don’t have exterior cell walls for protection, and environmental assaults can easily damage or destroy mammalian cells. Thus, the ability to develop a biomimetic cell wall (BCW) on their plasma membrane as a shield can advance various applications. A recent study published in Nature Communications has synthesized BCW with a framing template and a crosslinked matrix for shielding live mammalian cells. The framing template is a supramolecular DNA structure. The crosslinked matrix is a polyelectrolyte complex made of alginate and Pegylated-polylysine (PLL-MPEG, Nanosoft Polymers). As the entire procedure of BCW synthesis is strictly operated under physiological conditions, BCW-covered mammalian cells can maintain high bioactivity. More importantly, the data show that BCW can shield live mammalian cells from not only physical assaults but also biological assaults. Thus, this study has successfully demonstrated the synthesis of BCW on live mammalian cells with great potential of shielding them from environmental assaults. Nature Communications (2019) 10:2223.

Synergetic ER-targeting Liposome Nanocarriers with Anti-phagocytic property for Enhanced Tumors Theranostics

Multifunctional nanocarriers have been widely applied due to their enhanced effect on tumor therapeutics. Nevertheless, owing to the natural immune clearance mechanisms in living bodies, nanocarriers tend to be eliminated during blood circulation, thereby impeding their effective arrival at the tumor sites. In a recently published paper, the authors constructed a synergetic targeted liposome nanocarrier system named SELS functionalized with both a tumor identification ligand (anti-ER (Estrogen Receptor) antibody) and an immune targeting ligand (Self-Peptide (SP)). DSPE-PEG-Mal (Nanosoft Polymers) was used to conjugate targeting ligand. The anti-ER antibody could recognize and bind ER-positive breast cancer tissues in a specific way. SP could activate the CD47-SIRPα immune response, which reduced phagocytosis of the nanoparticles by macrophages. Both the enhanced targeting ability and anti-phagocytosis behavior could improve the tumor uptake of the nanocarriers and prevent their immune clearance in living systems. Therefore, drug-loaded SELS enabled improved tumor imaging and therapeutic performance in living systems.  Journal of Materials Chemistry B, 48(7 ) 1056-1063.  2019.